CS
APLT

Credit Suisse’s Applied Therapeutics APLT Stock Holding History

Credit Suisse’s Portfolio APLT Stock Details APLT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q3 		– Sell
-9
Closed – – 4030
2022
Q2 		$0 Sell
9
-11,175
-100% -$18.3K ﹤0.01% 3907
2022
Q1 		$23K Buy
11,184
+829
+8% +$2.22K ﹤0.01% 3539
2021
Q4 		$93K Buy
+10,355
New +$136K ﹤0.01% 4388
2021
Q1 		– Sell
-16,490
Closed -$363K – 4281
2020
Q4 		$363K Buy
16,490
+5,659
+52% +$118K ﹤0.01% 3914
2020
Q3 		$224K Buy
10,831
+2,927
+37% +$76.1K ﹤0.01% 3794
2020
Q2 		$286K Buy
+7,904
New +$331K ﹤0.01% 3605

Other funds holding APLT

Franklin Resources
Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return
Alyeska Investment Group
Alyeska Investment Group Chicago, Illinois $35.4B AUM 33.54% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Point72 Asset Management
Point72 Asset Management Stamford, Connecticut $78.1B AUM 55.25% 1-Year Est. Return
KCM
Knoll Capital Management Miami, Florida $180M AUM 66.11% 1-Year Est. Return
RSCM
Rock Springs Capital Management Baltimore, Maryland $1.7B AUM 93.03% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
AG
Artal Group Luxembourg $1.01B AUM 29.84% 1-Year Est. Return
LCM
Laurion Capital Management New York $2.29B AUM 75.73% 1-Year Est. Return

Credit Suisse's APLT Position: Q3 2022 in Review

Credit Suisse sold out of Applied Therapeutics (APLT) in Q3 2022, closing a stake of 9 shares.

Credit Suisse first reported a position in APLT in Q2 2020 and held it in 6 quarters. The position peaked at $363K in Q4 2020. 44 funds tracked by Wall St. Rank hold APLT as of Q3 2022.

  • Credit Suisse reported no remaining Applied Therapeutics position as of Q3 2022 after selling out during the quarter.
  • Credit Suisse sold 9 Applied Therapeutics shares in Q3 2022.
  • Credit Suisse first reported a position in Applied Therapeutics in Q2 2020 and held it in 6 quarters.
  • Credit Suisse's Applied Therapeutics position peaked at $363K in Q4 2020.
  • 44 funds tracked by Wall St. Rank held Applied Therapeutics as of Q3 2022.

Based on Credit Suisse's 13F filing for Q3 2022, filed 10 Nov 2022.